TBVAC partners

Partners in TBVAC are:

  • Université Libre de Bruxelles (ULB), Belgium
  • GSK-Biologicals (GSK-Bio), Belgium
  • Staten Serum Institut (SSI), Denmark
  • Armauer Hansen Research Institute (AHRI), Ethiopia
  • Centre National de la Recherche Scientifique (CNRS), France
  • Institut Pasteur (IPAS), France
  • Institut National de la Santé et de la Recherche Médicale (INSERM), France
  • University Lübeck (UNILU), Germany
  • Technical University of Munich (TUM), Germany
  • Max-Planck Institute for Infection Biology (MPIIB), Germany
  • University of  Ulm (ULM), Germany
  • Vakzine Projekt Management (VPM), Germany
  • National Institute for Infectious Diseases “Lazzaro Spallanzani” (INMILS), Italy
  • University of Palermo (UNIPA), Italy
  • Hôpital Le Dantec (LEDANTEC), Senegal
  • University of Cape Town (UCT), South Africa
  • Universidad de Zaragoza Facultad de Medicina (UNIZAR), Spain
  • Institute for Research in Biomedicine (IRB), Switzerland
  • University of Geneva (UNIGE), Switzerland
  • University Hospital of Basel (UNIBA-CH), Switzerland
  • Centre Hospital Universitaire Vaudois (CHUV), Switzerland
  • Leiden University Medical Center (LUMC), The Netherlands
  • Biomedical Primate Research Centre (BPRC), The Netherlands
  • Instituut voor Dierhouderij en Diergezondheid (ID-Lelystad), The Netherlands
  • MRC The Gambia (MRC), The Gambia 
  • University of Birmingham (BHAM), United Kingdom
  • Aston University (ASTON), United Kingdom 
  • Manchester University Medical School (MANU), United Kingdom
  • Imperial College of Science Technology and Medicine (ICSTM), United Kingdom
  • National Institute for Biological Standards (NIBSC), United Kingdom
  • University of Oxford (UOXF), United Kingdom
  • London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
  • Health Protection Agency Porton Down (HPA-PD), United Kingdom